Health Economics & Policy

Immunological response of metal containing implants under scrutiny
Health Economics & Policy

FDA: Immunological response of metal containing implants under scrutiny

The US FDA calls for a common engagement involving surgeons, scientists, patients and industry to collect evidence on implant materials. The goal is to develop a better understanding of materials science and the adverse biological responses induced by some materials considered to be biocompatible and though eliciting exaggerated reactions on some patients.

Health Economics & Policy

Burden of Disease: Can the Curve Be Flattened?

The growing number of hip arthroplasty procedures requires solutions and adequate planning to reduce the future burden of disease and its economic consequences. As revision has a severe impact on the patient’s quality of life and the healthcare economy, implant solutions with proven superior outcomes should be regarded as best practice.